APA (7th ed.) Citation

Morabito, C., Cohen, T., Gunsior, M., Nichols, A., Chung, J., Bernard, K., . . . Lumry, W. (2023). SUPPORT FOR STAR-0215 ADMINISTERED EVERY THREE- OR SIX-MONTHS FOR HEREDITARY ANGIOEDEMA: PHASE 1A Results. Annals of allergy, asthma, & immunology, 131(5), S32-S33. https://doi.org/10.1016/j.anai.2023.08.107

Chicago Style (17th ed.) Citation

Morabito, C., T. Cohen, M. Gunsior, A. Nichols, J. Chung, K. Bernard, P. Gustafson, and W. Lumry. "SUPPORT FOR STAR-0215 ADMINISTERED EVERY THREE- OR SIX-MONTHS FOR HEREDITARY ANGIOEDEMA: PHASE 1A Results." Annals of Allergy, Asthma, & Immunology 131, no. 5 (2023): S32-S33. https://doi.org/10.1016/j.anai.2023.08.107.

MLA (9th ed.) Citation

Morabito, C., et al. "SUPPORT FOR STAR-0215 ADMINISTERED EVERY THREE- OR SIX-MONTHS FOR HEREDITARY ANGIOEDEMA: PHASE 1A Results." Annals of Allergy, Asthma, & Immunology, vol. 131, no. 5, 2023, pp. S32-S33, https://doi.org/10.1016/j.anai.2023.08.107.